BIOVIT Selected as "BIG 3" Promising Small and Medium-Sized

Enterprises Consecutively for 2021


2021-03-01

Peptide Stability Platform (PSP) possessing Start-Up Biovit (CEO, Yong Tae Kim) has been awarded the recognition of Promising Small and Medium-Sized Enterprises (SMEs) yet another time for 2021.

BIG3 fields (system semiconductor/biohealth/future cars) are market potentials invested by the government. Despite having difficult circumstances, the BIG3 program has come a long way and proven positive results.

Biovit has been selected as one of the revolutionary biohealth company, not only being successful for proceeding in foreign markets, but also getting through the first steps in medicine development.

With the successful commercialization of the PSP technology, Biovit will continue their medicine development and stable market expansion with the help of commercialization and R&D aids.